Cargando…
Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients
PURPOSE: Real-life clinical outcomes of patients treated with anti-VEGF drugs for neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), or macular edema secondary to branch retinal vein occlusion (BRVO) are often inferior to results from randomized clinical trials. This...
Autores principales: | Ehlken, Christoph, Helms, Mandy, Böhringer, Daniel, Agostini, Hansjürgen T, Stahl, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745150/ https://www.ncbi.nlm.nih.gov/pubmed/29339917 http://dx.doi.org/10.2147/OPTH.S151611 |
Ejemplares similares
-
Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV
por: Wecker, Thomas, et al.
Publicado: (2017) -
Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment
por: Wecker, Thomas, et al.
Publicado: (2019) -
Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data
por: Ziemssen, Focke, et al.
Publicado: (2016) -
Aflibercept Does Not Suppress Angiopoietin-2 in Patients With nAMD or DME
por: Avery, Robert L., et al.
Publicado: (2023) -
Automatic Detection of AMD and DME Retinal Pathologies Using Deep Learning
por: Saidi, Latifa, et al.
Publicado: (2023)